Sensoria and RespondWell Announce Wearable Rehabilitative

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sensoria and RespondWell Announce Wearable Rehabilitative Patient Monitoring at CES 2015

LAS VEGAS, Jan. 5, 2015 (GLOBE NEWSWIRE) -- Redmond, Wash.-based Sensoria, a leading developer of wearable solutions, announced today at the International Consumer Electronics Show in Las Vegas that it has been working with RespondWell to create the next generation of rehabilitation patient monitoring using truly wearable textile sensing technology.

Sensoria's smart sock technology will enable physical therapy patients to perform gait and balance exercises from RespondWell and receive reliable and instant feedback from a virtual therapist on a tablet or large display screen. By imitating what they see on-screen, patients will receive correct, visual and easy to follow instructions for each exercise and are encouraged to complete the prescribed routines. This same feedback information can also be accessed and analyzed remotely and securely by the patient's therapist and healthcare team. Leveraging the Sensoria Developer Kit, this integrated solution enables the future of telehealth scenarios involving patient rehabilitation and healthy aging today.

"By using the Sensoria Sock we become part of the patient's daily workflow, which means more data collected on patient health status. Patients using our assessment and physical therapy solution can benefit from the dynamic feedback provided by the Sensoria sock and anklet. The Sensoria Developer Kit offers healthcare developers truly wearable devices to build seamless solutions for telehealth and gait monitoring," said RespondWell Chief Executive Officer John Grispon.

"Sensoria is two things: a development platform and an integrated suite of smart garments that can turn gait and activity analytics into meaningful behavioral feedback," said Sensoria Co-Founder and Chief Executive Officer Davide Vigano.

Gait exercises help improve dynamic balance and gait functions for elderly individuals. According to a May 2003 study published in the Journal of Clinical Rehabilitation, performing gait exercises regularly for twelve weeks improved dynamic balance and gait functions of frail elderly subjects.

In the future, RespondWell may also use advanced Sensoria wearables technology for stroke rehabilitation, disease management, sports rehabilitation and to improve general wellness. The RespondWell platform currently offers falls prevention, pulmonary, pre-diabetic and senior fitness modules. At the same time, it is designed to improve patients' rehabilitation experience and adherence using gamification, rewards and challenges.

The Sensoria smart sock is equipped with proprietary textile pressure sensors that connect to a lightweight anklet. The anklet is equipped with an accelerometer, local storage and Bluetooth Smart communication. The smart sock and anklet together measure a range of parameters including steps, repetitions, activity, balance and plantar pressure.

The data can be transmitted wirelessly to a mobile device for real-time alerts, and to the cloud for ex-post analytics and behavioral feedback.

Sensoria will feature a demonstration of the integrated RespondWell rehab solution at the company's booth (#74132) during the 2015 International CES, which runs January 6-9, in Las Vegas.

About Sensoria Inc.

Headquartered in Redmond, Wash., Sensoria Inc. is a leading developer of IoE (Internet of Everyone) wearable solutions that improve people's lives. Our vision is that The Garment is The Computer®. Our proprietary e-textile sensor platform enables Sensoria powered garments to deliver actionable information to health and fitness users in real-time. Sensoria® is a registered trademark of Sensoria Inc. For further information on Sensoria, visit www.sensoriainc.com .

About RespondWell

RespondWell develops a cloud-based Patient Engagement Platform to activate patients, drives provider and payer efficiencies and improves outcomes from the clinic or home. The Microsoft Kinect sensor and Sensoria Smart Sock are used to remotely monitor patient performance while patients receive rehab instruction and encouragement that includes challenge and reward. Data collection helps monitor patient condition status in both assessment and performance for a range of modules including falls prevention, pulmonary, senior fitness, pre-diabetic and general wellness. For more information on RespondWell, visit www.respondwell.com .

Media Contact: Luke Lappala o. 425.533.2928 c. 206.313.7520

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Eco Wave Power Expands Wave Energy Project in Europe

Updated Category News Views 229

Eco Wave Power Initiates Key Infrastructure Enhancements Eco Wave Power Global AB (publ) (NASDAQ: WAVE) is excited to unveil plans for crucial upgrades at its groundbreaking wave energy project. This groundbreaking initiative is set to harness ocean wave energy to produce clean electricity efficiently. Eco Wave Power, recognized as a leading company in onshore wave energy...

Continue Reading
Key Managerial Transactions Reported by Danske Bank A/S

Updated Category News Views 162

Recent Mandatory Transaction Notifications by Danske Bank A/S Danske Bank A/S is committed to transparency in financial transactions involving its managerial personnel. This communication signifies the bank's adherence to the EU Market Abuse Regulation and the requirements set by the Danish Financial Supervisory Authority (FSA) and Nasdaq Copenhagen. Understanding...

Continue Reading
Strategic Insights into Symbotic's Options Market Activity

Updated Category News Views 187

Overview of Options Activity for Symbotic Recently, significant investors have demonstrated a notably bearish outlook on Symbotic. This trend has been evidenced by the options activity surrounding the company's stock, symbolized by SYM. The strong presence of whales entering the market indicates a shift in investor sentiment, with nuances that are crucial for...

Continue Reading
South Coast AQMD Takes Action on Oil Facilities During Violations

Updated Category News Views 267

South Coast AQMD Addresses Oil Site Violations In a determined effort to safeguard public health and air quality, the South Coast Air Quality Management District (South Coast AQMD) has recently taken enforcement action against three oil and gas facilities in Los Angeles. These actions were prompted by public complaints and confirmed violations of air quality regulations,...

Continue Reading
BAM UK & Ireland and LoadSpring Solutions Innovate Project Management

Updated Category News Views 199

BAM UK & Ireland and LoadSpring Solutions Innovate Project Management BAM UK & Ireland, a prominent name in the construction and engineering sector, has taken a bold step forward by partnering with LoadSpring Solutions. This collaboration aims to revolutionize project management through an innovative solution known as LoadSpring INSIGHTS™. This groundbreaking platform...

Continue Reading